InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Enliven Therapeutics, Inc.

ELVN Clue Score23
United States Fiscal year ends December CIK 0001672619 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

30
Insider
Date
Role
Action
Shares
Price
Amount
Benjamin Hohl
17 Aug 2026
Chief Financial Officer
Sold on a plan
1,388
$59.35
$82.38K
Benjamin Hohl
17 Aug 2026
Chief Financial Officer
Sold on a plan
4,630
$58.35
$270.17K
Lori Anne Kunkel
6 Jul 2026
Director
Sold on a plan
5,889
$50.84
$299.42K
Lori Anne Kunkel
6 Jul 2026
Director
Sold on a plan
4,111
$49.98
$205.48K
Lori Anne Kunkel
5 Jun 2026
Director
Sold on a plan
354
$35.82
$12.68K
Lori Anne Kunkel
5 Jun 2026
Director
Sold on a plan
1,867
$35.36
$66.01K
Lori Anne Kunkel
5 Jun 2026
Director
Sold on a plan
7,779
$34.28
$266.66K
Richard A. Heyman
17 Feb 2026
Director
Sold on a plan indirect
1,230
$26.18
$32.20K
Joseph P Lyssikatos
6 Feb 2026
Chief Scientific Officer
Sold on a plan indirect
5,000
$29.04
$145.22K
Richard A. Heyman
20 Jan 2026
Director
Sold on a plan indirect
718
$26.96
$19.35K
Richard A. Heyman
20 Jan 2026
Director
Sold on a plan indirect
512
$26.46
$13.55K
Joseph P Lyssikatos
20 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
14,509
$26.90
$390.28K
Joseph P Lyssikatos
20 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
5,491
$26.37
$144.81K
Richard A. Heyman
9 Jan 2026
Director
Sold on a plan indirect
4,285
$25.00
$107.13K
Joseph P Lyssikatos
9 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
50,000
$29.13
$1.46M
Joseph P Lyssikatos
9 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
41,198
$24.90
$1.03M
Anish Patel
9 Jan 2026
Chief Operating Officer
Sold on a plan indirect
243
$28.50
$6.93K
Anish Patel
9 Jan 2026
Chief Operating Officer
Sold on a plan indirect
48,057
$27.98
$1.34M
Richard A. Heyman
8 Jan 2026
Director
Sold on a plan indirect
8,015
$25.04
$200.66K
Richard A. Heyman
8 Jan 2026
Director
Sold on a plan indirect
1,620
$25.00
$40.50K
Joseph P Lyssikatos
8 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
33,802
$24.92
$842.47K
Joseph P Lyssikatos
8 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
7,500
$20.13
$150.96K
Joseph P Lyssikatos
19 Dec 2025
Chief Scientific Officer
Sold on a plan indirect
5,000
$16.84
$84.21K
Anish Patel
8 Dec 2025
Chief Operating Officer
Sold on a plan indirect
1,705
$21.78
$37.13K
Anish Patel
8 Dec 2025
Chief Operating Officer
Sold on a plan indirect
4,958
$20.76
$102.94K
Joseph P Lyssikatos
19 Nov 2025
Chief Scientific Officer
Sold on a plan indirect
492
$23.09
$11.36K
Joseph P Lyssikatos
19 Nov 2025
Chief Scientific Officer
Sold on a plan indirect
12,008
$22.30
$267.79K
Samuel Kintz
17 Nov 2025
President and CEO
Sold on a plan indirect
12,500
$21.82
$272.74K
Anish Patel
7 Nov 2025
Chief Operating Officer
Sold on a plan indirect
613
$17.94
$11.00K
Anish Patel
7 Nov 2025
Chief Operating Officer
Sold on a plan indirect
6,054
$17.35
$105.04K
Show all 80 transactions →

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 30
Sales straight out of an exercise 39
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 482,634
History held since 16 Mar 2020